Pharma Packaging Solutions

NOVEMBER 14, 2024

Packaging must prevent interactions between the medication and external contaminants, as well as between the drug and its container. Tjoapack employs innovative packaging materials that are inert and non-reactive, ensuring that the medication remains chemically stable.

Packaging 52

Packaging Packaging Contamination Pharma Packaging 52

Pharma Packaging Solutions

SEPTEMBER 8, 2022

Packing materials that come in direct contact with pharmaceutical products—such as blister packs, bottles, vials, and ampules—are all examples of primary packaging. As the main line of defense between a drug and its environment, primary packaging must be able to prevent contamination and chemical alterations. .

Packaging 52

Packaging Packaging Drugs Pharma Packaging 52

Pharma Packaging Solutions

AUGUST 3, 2023

Material All medical device packaging should be manufactured using materials that are both known and traceable. Additionally, the materials used should be non-toxic, odorless, and non-leaching to prevent any possible contamination of the device the packaging is designed to contain.

Packaging 52

Packaging Packaging Pharma Packaging Contamination 52

pharmaphorum

NOVEMBER 24, 2022

Cleanrooms are critical in the development of pharmaceuticals, offering a controlled environment free from contamination to test new drugs and therapeutic devices. Each room is developed to deliver a specific environment to unique ISO standards to avoid contamination. The post Cleanrooms-on-demand: a more efficient future for pharma?

Manufacturing 98

Manufacturing Pharma Packaging Production Packaging 98

Pharma Packaging Solutions

NOVEMBER 8, 2024

Tjoapack employs advanced materials and sealing technologies to ensure that the packaging provides an effective barrier against contaminants. Regulatory Compliance Compliance with regulatory standards is essential in medical device packaging.

Packaging 52

Packaging Packaging Pharma Packaging Compliance 52